Industries de la santé

NEW YORK (GBI Research), 21 June 2012 - Argentina is boosting the health of their citizens thanks to strong government schemes that are providing medical attention to those that need it, while financially supporting the country’s in-house pharmaceutical production, according to a new report from healthcare experts GBI Research.

The new report shows that the Argentine pharmaceutical market...

LONDON, UK (GlobalData), 20 June 2012 - European healthcare is being transformed as a result of economic recession, as austerity measures reshape the way that countries run, states a new report by healthcare experts GlobalData.

The new report* looks at the sovereign debt crisis, formed by a collection of budget deficits created by insufficient tax revenue and excessive spending in across...

HAIFA, ISRAEL – June 19, 2012 -- Pluristem Therapeutics, Inc. (NASDAQCM:PSTI; TASE: PLTR) announced today at the 2012 Bio International Convention the results of a pre clinical study it conducted measuring the effectiveness of its Placental eXpanded (PLX) cells when administered intramuscularly(IM). Cell therapies are traditionally delivered through intravenous (IV) injections for...

NEW YORK (GBI Research), 14 June 2012 - The global market for biosimilar drugs is due to come under attack from popular generic drugs, as governments fight to control rising healthcare expenditure, according to healthcare experts GBI Research.

The new report* states that governments in emerging economies are struggling to match the soaring demand for cheaper drugs, due to an increase in...

HEIDELBERG, 12 June 2012 – Researchers in France and Sweden have discovered how one of the body’s own proteins is involved in generating chronic pain in rats. The results, which also suggest therapeutic interventions to alleviate long-lasting pain, are reported in The EMBO Journal.

Chronic pain is persistent and often difficult to treat. It is due, at least in part, to changes in...

Durham, NC – Bone grafts grown from purified stem cells originating from fat could lead to a more efficient way to regenerate bone and end the painful operations needed to collect a patient’s own bone for grafting. The results could have significant impact on those suffering from severe bone injuries or disease. 

In a study published in the June issue of STEM CELLS Translational...

LONDON, UK (GlobalData), 7 June 2012 - The head of global research and development (R&D) for Sanofi, Elias Zerhouni, stated on May 31 that the company intends to expand its presence in the diabetes market space. Currently, Sanofi markets Lantus (injectable insulin glargine from rDNA origin), and will likely be filing for a new drug application (NDA) of its once-daily GLP-1 receptor...

Toulouse, le 6 juin 2012 - Vexim (FR0011072602 ALVXM), société Med-Tech spécialisée dans la restauration anatomique mini invasive des fractures vertébrales, annonce la nomination de Marie-Pierre Hontas au poste de Directrice des Affaires Cliniques. Marie-Pierre Hontas dispose de 20 années d'expérience en recherche clinique internationale acquise dans l'industrie pharmaceutique et le...

The U.S. House of Representatives passed its version of the FDA user fee bill ( H.R. 5651) Wednesday 387-5. The vote comes on the heels of the Senate’s 96-1 vote passing their version of the bill ( S. 3187) last week. The different bills would need to be reconciled in a conference committee and receive approval from both chambers before receiving President Obama's signature.

Given...

Vitrines Sociétés

Voir toutes les vitrines